Copyright
©The Author(s) 2017.
World J Clin Oncol. Aug 10, 2017; 8(4): 343-350
Published online Aug 10, 2017. doi: 10.5306/wjco.v8.i4.343
Published online Aug 10, 2017. doi: 10.5306/wjco.v8.i4.343
Figure 1 Kaplan-Meier survival curves.
Survival time for BC vs CRC (P = 0.042, χ2 test). 1: Survival data of all patients with liver metastases of BC after TACP (n = 19). Median survival time 13.2 mo; 2: Survival data of patients with liver metastases of CRC after TACP (n = 17). Median survival time 9.3 mo. BC: Breast cancer; CRC: Colorectal cancer; TACP: Trans-arterial chemoperfusion.
- Citation: Gruber-Rouh T, Langenbach M, Naguib NNN, Nour-Eldin NEM, Vogl TJ, Zangos S, Beeres M. Trans-arterial chemoperfusion for the treatment of liver metastases of breast cancer and colorectal cancer: Clinical results in palliative care patients. World J Clin Oncol 2017; 8(4): 343-350
- URL: https://www.wjgnet.com/2218-4333/full/v8/i4/343.htm
- DOI: https://dx.doi.org/10.5306/wjco.v8.i4.343